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Abstract.
Purpose. To develop a novel treatment planning process (TPP) with simultaneous
optimization of modulated photon, electron and proton beams for improved treatment
plan quality in radiotherapy.
Methods. A framework for fluence map optimization of Monte Carlo (MC) calculated
beamlet dose distributions is developed to generate treatment plans consisting of
photon, electron and spot scanning proton fields. Initially, in-house intensity
modulated proton therapy (IMPT) plans are compared to proton plans created by
a commercial treatment planning system (TPS). A Triple Beam radiotherapy (TriB-
RT) plan is generated for an exemplary academic case and the dose contributions
of the three particle types are investigated. To investigate the dosimetric potential,
a TriB-RT plan is compared to an in-house IMPT plan for two clinically motivated
cases. Benefits of TriB-RT for a fixed proton beam line with a single proton field are
investigated.
Results. In-house optimized IMPT are of at least equal or better quality than TPS
generated proton plans and MC-based optimization shows dosimetric advantages for
inhomogeneous situations. Concerning TriB-RT, for the academic case, the resulting
plan shows substantial contribution of all particle types. For the clinically motivated
case, improved sparing of organs at risk close to the target volume is achieved compared









































































to IMPT (e.g. myelon and brainstem Dmax -37%) at cost of an increased low dose bath
(healthy tissue V10% +22%). In the scenario of a fixed proton beam line, TriB-RT plans
are able to compensate the loss in degrees of freedom to substantially improve plan
quality compared to a single field proton plan.
Conclusion. A novel TPP which simultaneously optimizes photon, electron and
proton beams was successfully developed. TriB-RT shows the potential for improved
treatment quality and is especially promising for cost-effective single-room proton
solutions with a fixed beamline in combination with a conventional linac delivering
photon and electron fields.
Keywords: Triple Beam radiotherapy, TriB-RT, simultaneous optimization, Monte Carlo
1. Introduction
The fundamental goal of radiotherapy is to deliver a therapeutically efficacious dose to
a target volume while limiting the exposition of normal tissue (NT). The exploitation
of the so-called therapeutic window allows for good prospects of tumour control and
low probability of adverse effects. Many technological advances in the past decades
have paved the way to achieve this goal. Increasingly complex field arrangements,
sophisticated treatment techniques, image-guidance for patient position verification and
anatomy tracking have enabled steeper dose gradients at the border of the high dose
region and lower doses to the NT (Schultheiss 2017). In photon radiotherapy, inverse
treatment planning techniques have enabled a paradigm change towards modulated
therapies such as intensity modulated radiotherapy (IMRT) and volumetric modulated
arc therapy (VMAT) (Yu 1995; Bortfeld 2006; Otto 2008; Cho 2018). The enabling
of both intensity and energy modulation is also promising for electron beams, which
are well suited for treating superficially located targets due to the high dose at the
surface and the steep dose fall-off at larger depths (Ding et al. 1996; Hogstrom et al.
2006; Henzen et al. 2014b). The beneficial dosimetric characteristics of charged particles
are even more pronounced for proton beams. Proton therapy can provide a dosimetric









































































advantage over conventional photon therapy as the depth-dose characteristics of protons
allow dose reduction in NT proximal and distal to the target volume (Paganetti 2016).
However, due to scattering of protons in patient tissue, the penumbra of a clinical proton
beam is larger than of a clinical photon beam from a certain penetration depth, which
may yield higher dose to laterally situated NT (Deluca et al. 2007; Mohan et al. 2017).
The combination of more than one particle type in radiotherapy is well established
in clinical practice by using electron therapy subsequent to photon irradiation for
postmastectomy chest wall irradiation (Kirova et al. 2007). More sophisticated
approaches using photon and electron beams in mixed beam radiotherapy (MBRT)
allow for ameliorated treatment quality for a wide range of indications compared to
photon or electron only therapy (Mueller et al. 2017; Mı́guez et al. 2017; Renaud et
al. 2017; Mueller et al. 2018b). Morevover, combined proton–photon treatments have
recently been investigated by Unkelbach et al. 2018 under consideration of limited proton
treatment slots. As an increasing number of hospitals install single-room proton therapy
facilities, combining proton therapy with linear accelerator provided photon and electron
beams becomes a clinical option. However, to the best of our knowledge, there is no
study on the development of a treatment planning process (TPP) with simultaneous
optimization of photon, electron and proton beams in radiotherapy.
The purpose of this work is twofold: Firstly, an in-house solution for Monte Carlo (MC)
based IMPT plan optimization is developed and compared to proton plans created
by a commercial treatment planning system (TPS). The second aim is to develop
Triple Beam radiotherapy (TriB-RT), a novel TPP with simultaneous optimization
of modulated photon, electron and proton beams. Fluence map optimization of MC
calculated beamlet dose distributions is used to harvest the benefits of all three beam
types. An academic case is used to illustrate the characteristics of TriB-RT and two
clinically motivated cases are investigated by comparing TriB-RT plans with IMPT
plans.








































































2. Materials and Methods
2.1. Treatment planning process for TriB-RT
In the first step of the TPP for TriB-RT, the CT dataset is imported into a research
version of the Eclipse TPS (Varian Medical Systems, Palo Alto, CA). The clinically
relevant structures such as the planning target volume (PTV) and organs at risk (OARs)
are contoured and the physician’s intent for prescription dose and fractionation scheme is
defined. Subsequently, photon, electron and proton beam directions including isocenter
positions are manually set up. Following the principles of MBRT planning (Mueller et
al. 2017), supported beam energies and collimator rotation are defined for photon and
electron fields. The photon and electron plan contributions are designed to be delivered
on a TrueBeam (Varian Medical Systems, Palo Alto, CA) with a source-axis distance of
100 cm, which is equipped with a Millennium 120 pMLC (Varian Medical Systems, Palo
Alto, CA). All photon and proton beams are defined in a single isocenter group around
the PTV, whereas electron fields are set up with reduced source to surface distance
(SSD) of 70–85 cm to minimize air scattering (Mueller et al. 2018a). In this work,
proton beam contribution is designed to be delivered using the the ProBeamTM spot
scanning system (Varian Medical Systems, Palo Alto, CA) with a source-axis distance of
228 cm and spot candidates to cover the target are determined using the Eclipse TPS.
If a proton field is not able to adequately cover the superficial part of the PTV due
to the lower energy boundary, a range shifter (RS) is added as a pre-absorber to the
respective proton field. Beamlet dose calculations are performed using MC simulations
as described in the subsequent paragraph. For the photon and electron fields, a beamlet
grid with a resolution of 0.5 × 0.5 cm2 (at isocenter level) is positioned on the center
plane of the photon multileaf collimator (pMLC). For the spot scanning proton fields, the
contribution of each individual spot is considered a beamlet dose. For the simultaneous
optimization process of all particle types, the beamlet dose distributions in units Gy per
MU and the dose objectives with priorities are input to the optimizer and the output is









































































the absolute weight of each beamlet in MUs.
2.2. Monte Carlo simulations
The Eclipse TPS is interfaced with the Swiss Monte Carlo Plan (SMCP) framework
(Fix et al. 2007) to initiate beamlet dose calculation. For the 6 MV photon beamlets,
a validated phase space beam model (Magaddino et al. 2011) and VMC++ (Kawrakow
et al. 2000) dose calculation is applied. Electron beamlets with energies 6, 9, 12, 15,
18 and 22 MeV are calculated using a multiple source MC beam model (Henzen et al.
2014a) and patient dose calculation is done using the electron macro MC algorithm
(Neuenschwander et al. 1992, 1995; Fix et al. 2013a). For proton beamlets, a generic
beam model of the ProBeamTM system is used, which is commissioned for proton
energies between 70–244 MeV and includes an optional RS with a water equivalent
thickness of 5.7 cm. Dose calculation is performed with the proton macro MC algorithm
(Fix et al. 2013b; Kueng et al. 2019). A voxel size of 2.5 × 2.5 × 2.5 mm3 is used for all
dose calculations in this work. The average relative statistical uncertainty (one standard
error of the mean) of the voxels with dose values higher than 50% of the maximal
dose is below 1% for all presented dose distributions, as determined by a history-by-
history method (Walters et al. 2002). The statistical uncertainty in the beamlet dose
distributions can propagate to variability in the subsequent optimization process (Jeraj
et al. 2000). This is mitigated by ensuring the relative statistical uncertainty of each
individual beamlet dose distribution to be lower than 2%.
2.3. TriB-RT and in-house IMPT optimization
In order to optimize TriB-RT and in-house IMPT plans, dose-volume objectives (Wu
et al. 2000), generalized equivalent uniform dose (gEUD) objectives (Niemierko 1999) as
well as NT objectives (Varian Medical Systems 2014) are defined by the planner. The
objective function to be minimized in the optimization process is defined as a weighted












































































wk · fDVk +
NgEUD∑
j=1
wj · f gEUDj +
NNT∑
l=1
wl · fNTl , (1)




θ(ak · (Di −Dk)) · θ(ak · (D(Vk) −Di)) · (Di −Dk)2
Ni
(2)
and wj is the weight of the jth of NgEUD gEUD objectives
f gEUDj = θ(gEUD(t, j) − gEUDj) · (gEUD(t, j) − gEUDj)2. (3)
In a dose-volume objective, Di is the dose in the ith of MK voxels of the considered
structure, Dk is the objective dose, D(Vk) is the dose to at least the tolerated volume
Vk and θ is the Heaviside step function. Upper and lower objectives are identified








is characterized by a tissue-specific parameter t and Di is the dose






vi · θ(Di −DNTi ) · (Di −DNTi )2, (4)
where Vl is the volume and Ml the number of voxels of the NT structure l, vi is the
fractional volume overlap of the voxel i with the NT structure, Di is the dose delivered
to the voxel i and DNTi is the desired dose at voxel i defined by
DNTi =
 f0 · e
−k(xi−xstart) + f∞ · (1 − e−k(xi−xstart)) if xi ≥ xstart
f0 otherwise
, (5)
where f0 is the start dose, f∞ the end dose, k the fall-off parameter, xi the distance of
the voxel i to the closest PTV voxel and xstart is the start distance.
Fluence map optimization (FMO) is applied to determine the optimized MUs of each
beamlet for both TriB-RT and IMPT optimization. In this work, a limited-memory
Broyden–Fletcher–Goldfarb–Shanno (L-BFGS) algorithm (Broyden 1970; Nocedal et
al. 1999) is applied, which belongs to the class of Quasi-Newton methods. The length of
the L-BFGS history is set to 4 and the optimization continues for at most 104 iterations
or if the relative difference of the objective function value to the previous value is smaller
than 10−8 for three consecutive iterations.









































































To emphasize the fundamental characteristics of TriB-RT, an academic situation is
investigated. The academic case consists of a cubic 30 × 30 × 30 cm3 homogeneous
water phantom with cuboid OARs and PTV, shown in figure 1. The PTV with a
base of 10 × 10 cm2 is located 0.5 cm from the surface, reaching to a depth of 14 cm in
the water phantom. There are two cuboid OARs (base 2 × 10 cm2) located at a close
lateral proximity of 0.5 cm on opposing sides of the PTV. The two remaining sides are
not covered by OARs. There is an additional cubic OAR with a base length of 5 cm
















Figure 1: Left: 3D view of the academic case with PTV (red) and OARs (yellow). Right:
Field setup for the photon (X), electron (E) and proton (P) fields.
For the photon fields, two field directions at gantry angle 0◦ and 180◦ are defined.
Electron fields and a spot scanning proton field are set up from a single direction at
gantry angle 0◦.
An arbitrary dose of 100 Gy is prescribed to the median dose of the PTV. Upper and
lower dose-volume objectives are set on the PTV to ensure homogeneous coverage and
maximum dose objectives Dmax = 0 Gy are defined for the three OARs.









































































2.5. Head and neck case
The first clinically motivated case is a head and neck patient with a mostly superficial
PTV which is covered by a bolus. The structures and field setup of the head and neck
case are shown in figure 2. For this case, a coplanar setup is investigated and the














Figure 2: Left: 3D view of the head and neck case with PTV and OARs. Right: Field setup
for the photon, electron and proton fields.
Table 1: Coplanar setup of the photon fields (isocentric), electron fields (3 isocenters) and
spot scanning proton fields (isocentric) for the head and neck case.
Gantry [◦] Energy SSD [cm]
Photon fields
35 6 MV 95.9
111 6 MV 96.5
138 6 MV 95.6
162 6 MV 93.2
348.5 6 MV 94.5
Electron fields
38.5 6, 9, 12, 15, 18, 22 MeV 71.0
57 6, 9, 12, 15, 18, 22 MeV 76.6
90 6, 9, 12, 15, 18, 22 MeV 80.1
Proton fields
30 88.1-147.6 MeV (18 layers) with RS 223.3
90 87.6-143.6 MeV (17 layers) with RS 223.9
120 88.9-144.9 MeV (17 layers) with RS 224.1









































































A prescription dose of 66 Gy to be delivered in 33 fractions of 2 Gy is assigned to
the median dose of the PTV. Clinically motivated optimization objectives focus on
homogeneous coverage of the PTV and sparing of OARs, with focus on maximum dose-
volume objectives for serial organs and mean dose objectives (gEUD with t = 1) on
parallel organs. An additional NT objective is set on the healthy tissue for improved
dose conformity.
2.6. Pelvic case
The second clinically motivated case is a lymphatic tumor in the pelvic region. The PTV
is surrounded by various OARs such as bowels, rectum, bladder and femoral heads. The










Figure 3: Left: 3D view of the pelvic case with PTV and OARs. Center: Field setup for
the photon and electron fields. Right: Proton field in coronal view.
For this case, single proton field at a fixed proton gantry angle of 270◦ is defined,
again emulating the scenario of a fixed horizontal beamline proton facility. Photon
and electron fields are set up in a coplanar manner around the target volume. The
corresponding field parameters are indicated in table 2. A prescription dose of 50.4 Gy
to be delivered in 28 fractions of 1.8 Gy is assigned to the median dose of the PTV.
Clinically motivated optimization objectives focus on homogeneous coverage of the PTV
and sparing of OARs, with focus on maximum dose-volume objectives for serial organs
and mean dose objectives (gEUD with t = 1) on parallel organs. An additional NT









































































objective is set on the healthy tissue for improved dose conformity.
Table 2: Setup of the photon fields, electron fields and spot scanning proton field for the pelvic
case. A coplanar setup is chosen for the photon and electron fields and a fixed horizontal proton
beamline is assumed.
Gantry [◦] Energy SSD [cm]
Photon fields
16 6 MV 95.7
46 6 MV 93.3
166 6 MV 83.8
219 6 MV 81.4
265 6 MV 88.7
301 6 MV 95.7
334 6 MV 97.3
Electron fields
16 6, 9, 12, 15, 18, 22 MeV 75.1
344.5 6, 9, 12, 15, 18, 22 MeV 70.1
Proton field
270 86.8-177.8 MeV (27 layers) w/ RS 218.8
2.7. Analysis
In-house vs. TPS IMPT: The plan quality of the new TriB-RT TPP will be
compared to in-house optimized IMPT plans. Therefore, in order to first assess the
quality of in-house optimized IMPT plans, a plan comparison between an in-house
IMPT plan and a corresponding multi-field optimized (MFO) proton plan generated
in the Eclipse TPS is performed. The body structure of the clinically motivated head
and neck case is assigned a fixed Hounsfield number 0, therefore masking all tissue
inhomogeneities. This serves the purpose of eliminating potential differences in the
underlying dose calculation algorithms for the two optimization approaches, under
the premise that the TPS convolution superposition algorithm and the pMMC dose
calculation are equivalent in water. The resulting TPS plan is re-calculated using
pMMC and compared to the in-house optimized IMPT plan by means of DVHs and
dose distributions.
The same investigation is carried out for the clinically motivated head and neck case









































































for the CT set including tissue heterogeneities. Again, the resulting TPS plan is re-
calculated using pMMC and compared to the in-house optimized IMPT plan by means
of DVHs and dose distributions.
TriB-RT proof of concept: As a proof of concept for the newly introduced
TPP, a TriB-RT plan is generated for the academic case and is investigated for dose
contributions of the individual particle types to the target volume.
TriB-RT vs. IMPT: Next, for the clinically motivated head and neck case, TriB-
RT is compared to an three-field in-house IMPT plan. The TriB-RT plan is investigated
for dose contributions of the individual particle types. Plan quality is compared between
the TriB-RT and a three-field IMPT plan by means of DVHs, PTV dose homogeneity
and OAR dose-volume parameters.
TriB-RT vs. IMPT (single fixed proton beam): As a final investigation, a
fixed proton beam line with a single horizontal beam direction is emulated, as it could
be present at a single-room low cost proton facility. For both the clinically motivated
head and neck and plevic case, a single field proton plan (1F-PT) is generated and
compared to a TriB-RT (1P) plan using the same single proton field, but still allowing
all introduced photon and electron beam directions. Again, plan quality is compared
between the TriB-RT (1P) and 1F-PT plan by means of DVHs, PTV homogeneity and
OAR dose-volume parameters.
TriB-RT vs. VMAT: For the plevic case, the resulting TriB-RT (1P) and 1F-PT
plan are additionally compared to the clinically applied VMAT plan (4 co-planar half
arcs around the right body side).











































































For the clinically motivated head and neck case, the plan comparison between an MFO
proton plan generated in the TPS and in-house optimized IMPT plan is presented in
Appendix A for the water equivalent scenario. The corresponding dose distributions for
a representative slice of the planning CT and the resulting DVHs are shown in figure
A1. The MC re-calculation of the TPS optimized plan shows dose differences of up to
-5% compared to the analytical TPS dose calculation algorithm. These differences
are predominantly in areas of steep dose gradients, where distance-to-agreement is
<1 mm. This demonstrates that for a water equivalent situation, the TPS analytical
dose calculation algorithm and the pMMC algorithm are equivalent. Comparing the
in-house optimized IMPT plan to the re-calculated TPS proton plan, it can be observed
that the in-house optimized IMPT plan shows a more conformal dose distribution to the
target volume. Local dose differences of up to -25% of the prescription dose (corresponds
to up to −16.5 Gy over the entire course of treatment) can be observed in the NT area
enclosed by the target volume. Considering the DHVs, only small differences can be
observed between the two plans.
The results of the analogue investigation for the clinically motivated head and neck case
including tissue inhomogenities are shown in figure 4. Larger differences between the
re-calculated and the original TPS plan can be observed in this case, with differences
of up to -20%. This propagates to differences in the DVHs, where a degradation of
the PTV DVH can be observed for the re-calculated plan compared to the original
TPS plan. The in-house optimized IMPT plan in contrast is optimized based on MC
calculated beamlet dose distribution and thus does not suffer from degradation between
optimized and re-calculated plan. The resulting plan achieves excellent conformity and
dose homogeneity in the target volume.
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Figure 4: Top: Dose distributions of the TPS optimized proton plan (left), the same
plan recalculated with MC (center), and the in-house optimized IMPT plan (right) for a
representative slice of the planning CT, with PTV contour indicated in red. Middle: Relative
dose difference (% of prescription dose) between the re-calculated and original TPS plan
(left) and between in-house IMPT and MC re-calculated TPS plan (right). Bottom: DVHs
comparing the resulting TPS optimized proton plan (solid), re-calculated TPS plan (dash-dot)
and in-house optimized IMPT plan (dashed) for the head and neck case.








































































3.2. TriB-RT: Academic case
As a proof of concept, a TriB-RT plan is generated for the academic case and the





Figure 5: Top: Dose contributions by photon, electron and proton beams to the resulting
TriB-RT plan for the academic case. Bottom: Total dose distribution and profiles indicating
the respective contributions of the three particle types and corresponding dose profiles along the
indicated arrows.
The spatial dose distributions show that the photon fields contribute mainly to the
lateral boundaries of the target volume, where OARs are close-by. As expected, electron
contribution can only be observed in the superficial part of the target volume. The
proton field contributes dose to almost the entire target volume. The contribution
to the mean dose in the PTV are 21.7%, 4.2% and 74.1% for the photon, electron and
proton beams, respectively. Considering the total dose distribution, a very homogeneous
and conformal coverage of the target volume can be observed.









































































3.3. TriB-RT: Head and neck case
A TriB-RT plan is compared to our in-house optimized IMPT plan for the clinically
motivated head and neck case and the resulting DVHs are shown in figure 6.
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Figure 6: DVHs comparing the resulting TriB-RT (solid) and IMPT (dashed) plan for the
head and neck case.
Very similar PTV dose homogeneity is achieved for both the TriB-RT and the IMPT
plan with a homogeneity index HI := V95% − V107% of 98.9% and 98.3%, respectively.
Considering the OARs, TriB-RT shows improved dosimetric parameters for all organs
except for the contralaterally located OARs and the ipsilateral lens, as shown in table
3. For this clinically motivated case, IMPT is beneficial in reducing the volume of
the dose bath to the healthy tissue V10% (volume receiving 10% of the prescribed dose
or more), which is 490 cm3 for IMPT compared to 599 cm3 for TriB-RT. However, no
substantial differences in V20% can be observed. The dose contributions of the generated
TriB-RT plan are shown in figure 7 for a representative slice of the patient CT. It can be
observed that the photon dose contribution is most prominent in the boundary region
of the target volume. The electron fields contribute minorly to the superficial part of
the PTV, while the contribution of the proton fields is dominating in the corpus of the
target volume. The contribution to the mean dose in the PTV are 10.0%, 4.3% and
85.7% for the photon, electron and proton beams, respectively. This result suggests
that for this case, a 3-field IMPT plan yields an excellent treatment plan, but small








































































Table 3: Dosimetric parameters for the clinically motivated head and neck case. TriB-RT
and IMPT are compared for the case of 3 proton fields (2nd and 3rd column) and one single
proton field (4th and 5th column), superior values are indicated in bold.
Plan IMPT (3P) TriB-RT (3P) 1F-PT TriB-RT (1P)
PTV - HI 98.3% 98.9% 93.9% 98.7%
Inner ear l. - Dmean 5.79 Gy 4.77 Gy 27.15 Gy 7.73 Gy
Lacrimal gland l. - Dmean 4.26 Gy 3.56 Gy 24.79 Gy 4.33 Gy
Brain - D1% 24.78 Gy 23.87 Gy 44.62 Gy 38.56 Gy
Brainstem - Dmax 3.52 Gy 2.21 Gy 22.59 Gy 10.03 Gy
Myelon - Dmax 9.86 Gy 6.28 Gy 35.72 Gy 22.57 Gy
Eye l. - Dmax 14.39 Gy 11.74 Gy 38.95 Gy 14.46 Gy
Eye r. - Dmax 0.07 Gy 2.13 Gy 0.04 Gy 2.46 Gy
Lens l. - Dmax 1.17 Gy 1.47 Gy 19.51 Gy 2.7 Gy
Lens r. Dmax 0.04 Gy 1 Gy 0.03 Gy 1.16 Gy
Parotid gland r. - Dmean 0.01 Gy 0.33 Gy 0.01 Gy 0.64 Gy
Healthy Tissue - V10% 490 cm
3 599 cm3 655 cm3 849 cm3
Healthy Tissue - V20% 375 cm
3 369 cm3 509 cm3 493 cm3
PTV Dmean photon contribution - 10.0% - 18.2%
PTV Dmean electron contribution - 4.3% - 26.9%
PTV Dmean proton contribution 100% 85.7% 100% 54.9%
improvements can be achieved allowing additional photon and electron beams.
However, plan quality of a pure proton plan is compromised when only a single beam
direction is available. This is illustrated by the DVHs in figure 8, where a TriB-RT
plan using a single proton field (1P) is compared to a single field proton plan (1F-PT).
The proton field is applied at a gantry angle of 90◦, emulating a fixed proton beam
line. The DVHs indicate that the compromised plan quality of the 1F-PT plan can be
improved by introducing photon and electron fields in the plan optimization process.
This is confirmed when investigating the dosimetric parameters as listed in table 3. With
exception of the contralateral OARs and the dose bath V10%, TriB-RT (1P) outperforms
the 1F-PT plan. It can be observed that the PTV homogeneity and the dosimetric
parameters of numerous OARs (e.g. inner ear, lacrimal gland, ipsilateral eye) can be
restored to the values of the 3-field IMPT plan by allowing photon and electron beams
in addition to the single proton field. Again, the dose contributions of the generated
TriB-RT plan are shown in figure 9 for a representative slice of the patient CT.
For this TriB-RT plan, the contribution to the mean dose in the PTV are 18.2%, 26.9%


















































































Figure 7: Top: Dose distributions by photon, electron (dose scaled by a factor of 10 for
visibility) and proton beams to the resulting TriB-RT plan for the head and neck case. Bottom:
Total dose distribution and profiles indicating the respective contributions of the three particle
types and corresponding dose profiles along the indicated arrows.
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Figure 8: DVHs comparing the resulting TriB-RT (1P) (solid) and 1F-PT (dash-dotted) plan
for the head and neck case.

















































































Figure 9: Top: Dose distributions by photon, electron and proton beams to the resulting
TriB-RT plan for the head and neck case with only one proton field direction (90◦) available.
Bottom: Total dose distribution and profiles indicating the respective contributions of the
three particle types and corresponding dose profiles along the indicated arrows.
and 54.9% for the photon, electron and proton beams, respectively. Compared to the
TriB-RT plan with three proton fields, the contribution of both photon and electron
beams is substantially increased, showing the potential of these particles to ameliorate
PTV dose homogeneity and conformity and sparing of OARs.
3.4. TriB-RT: Pelvic case
For the clinically motivated pelvic case, a plan comparison between a TriB-RT plan
(one proton field), a single field proton plan (1F-PT), and the clinically applied VMAT
plan (4 half arcs) is carried out. The corresponding DVHs are indicated in figure 10.
As supported by the dosimetric values in table 4, both the VMAT and the TriB-RT
plan achieve excellent PTV homogeneity of 99.8% and 99.4%, respectively. The VMAT
plan shows substantially larger dose to all OARs and increased low dose bath compared
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Figure 10: DVHs comparing the resulting TriB-RT (1P) (solid), 1F-PT (dash-dotted) and
clinical VMAT (dashed) plan for the for the pelvic case.
to the 1F-PT and the TriB-RT plan. While the low dose bath V10% is larger for the
Table 4: Dosimetric parameters for the clinically motivated pelvic case. The clinically applied
VMAT plan is compared to a single field proton plan and TriB-RT plan, superior values are
indicated in bold.
Plan VMAT 1F-PT TriB-RT (1P)
PTV - HI 99.8% 96.7% 99.4%
Bladder Wall - Dmean 14.01 Gy 6.65 Gy 5.44 Gy
Bowel - Dmean 3.28 Gy 0.66 Gy 0.96 Gy
Rectum Wall - Dmean 4.13 Gy 0.00 Gy 2.02 Gy
Femoral Head r. - Dmax 47.12 Gy 52.62 Gy 40.98 Gy
Femoral Head l. - Dmax 3.78 Gy 0.05 Gy 5.09 Gy
Healthy Tissue - V10% 4891 cm
3 1162 cm3 1805 cm3
Healthy Tissue - V20% 3344 cm
3 997 cm3 1014 cm3
PTV Dmean photon contribution 100% - 18.8%
PTV Dmean electron contribution - - 47.9%
PTV Dmean proton contribution - 100% 33.3%
TriB-RT plan compared to the proton plan, no substantial differences are seen in V20%.
Lower doses are achieved in certain OARs with the 1F-PT plan compared to TriB-RT
at cost of loss in PTV homogeneity and higher dose in other organs such as bladder
and ipsilateral femoral head. The dose contributions of the TriB-RT plan for the three
beam types are shown in figure 11 for a representative slice of the patient CT. It can
be observed that the electron beams deliver a substantial contribution to the superficial
part of the target volume, while the photon beams contribute mainly to the boundary


















































































Figure 11: Top: Dose distributions by photon, electron and proton beams to the resulting
TriB-RT plan for the pelvic case. Bottom: Total dose distribution and profiles indicating the
respective contributions of the three particle types and corresponding dose profiles along the
indicated arrows.
regions of the PTV. The contribution to the mean dose in the PTV are 18.8%, 47.9%
and 33.3% for the photon, electron and proton beams, respectively.
4. Discussion
In this work, TriB-RT is presented - an MC-based TPP featuring the simultaneous
optimization of photon, electron and proton beams. As a special case of this framework,
MC-based IMPT optimization is enabled, which for an exemplary case shows at least
equal plan quality compared to a corresponding proton plan generated in the Eclipse
TPS. Other work has demonstrated the drawbacks of the TPS proton optimization
due to the use of simplified dose calculation algorithms (Liu et al. 2019). With the
presented in-house IMPT optimization, multi-field proton optimization based on MC
beamlet calculation at custom calculation grid size is performed. Therefore, assuming
no machine constraints, the resulting proton dose distributions are expected to be
deliverable as such and no degradation due to simplified dose calculation has to be
expected. Additional photon and electron fields are defined and all three particle









































































types are simultaneously optimized in the process of generating a TriB-RT plan. It
is noteworthy that although each proton field itself is able to cover the target volume on
its own, a dosimetrically superior plan is found when allowing photon and electron
beam contributions. For the investigated cases, photon beam contribution is most
pronounced at the boundary of the target volume. This is consistent with the expected
benefits of photon beams compared to proton beams regarding the steepness of the
lateral penumbra and illustrates the potential of using photon beams to spare OARs in
close proximity of the target volume, at cost of an increased low dose bath. Electron
beam contribution is shown at the superficial parts of the respective target volumes.
It is not intuitively obvious that electron beams are dosimetrically superior to proton
beams for superficial targets. Both electron beams and proton spots have a larger
penumbra compared to photon beams (Hogstrom et al. 2006; Safai et al. 2008), but
have a finite range and are thus suited to reduce the low dose bath to normal tissue.
This emphasizes the strength of the simultaneous optimization approach - the user bias
is limited to choice of suitable beam directions and optimization objectives. All other
aspects of the optimization such as relative contribution of the three particle types is
incorporated in the optimization problem. The dosimetric benefit of TriB-RT compared
to a proton only plan is substantially larger in the case, where a fixed proton beamline
scenario with a single field is investigated. This indicates the potential of TriB-RT in
a hospital environment, where an existing machine park of conventional linacs, which
are able to deliver photon and electron beams, is extended with a cost-effective single-
room proton solution. The total cost of a TriB-RT treatment will therefore depend on
the cost-efficiency of the individual treatment machines delivering the photon, electron
and proton contribution and will depend on many parameters such as construction,
personnel and maintenance cost (Goitein et al. 2003).
For all investigated cases, TriB-RT provides a better solution to the optimization
problem compared to IMPT plans. It should however be noted that the fluence map
optimized TriB-RT plans provide a best-case solution to the optimization problem









































































without the immediate demand for deliverability. Machine constraints could apply to the
proton plans and the optimized photon and electron fluence maps would require either
leaf sequencing of the pMLC (Gregoire et al. 2010) or a direct aperture optimization
(DAO) approach (Shepard et al. 1999; Romeijn et al. 2005) to determine deliverable
dose distributions. These aspects will be investigated in future work.
As with all treatment techniques in radiotherapy including TriB-RT, the final
uncertainty of the dose distribution delivered to a patient depends on numerous factors.
IMPT plans are known to be very sensitive to range and setup uncertainties, which
could compromise treatment effectiveness (Lomax 2008a,b), whereas photon IMRT has
been shown to be less sensitive to these uncertainties (Müller et al. 2015). Apart from
the dosimetric benefits of TriB-RT for a static situation, treatment plans consisting
of all three particle types might therefore be more robust against inter- and intra-
fraction uncertainties compared to IMPT alone. Renaud et al. 2019 have however
concluded that for MBRT, robust optimization was required to maintain adequate target
coverage under consideration of a set of positioning error scenarios. Given the non-
uniformity of the dose distributions of the individual particle types in the presented
TriB-RT plans, the assessment of such uncertainties is key to move towards clinical
implementation. Robustness assessment and robust optimization of TriB-RT plans will
therfore be investigated in future work.
5. Conclusion
TriB-RT, a novel treatment planning process with simultaneous optimization of
modulated photon, electron and proton beams was successfully developed and studied
for an academic and two clinically motivated cases. TriB-RT shows the potential
for improved treatment quality and is especially promising for cost-effective single-
room proton solutions with a fixed beamline in combination with a conventional linac
delivering the photon and electron fields.
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Figure A1: Top: Dose distributions of the TPS optimized proton plan (left), the same
plan recalculated with MC (center), and the in-house optimized IMPT plan (right) for a
representative slice of the planning CT, with PTV contour indicated in red. Middle: Relative
dose difference (% of prescription dose) between the re-calculated and original TPS plan
(left) and between in-house IMPT and MC re-calculated TPS plan (right). Bottom: DVHs
comparing the resulting TPS optimized proton plan (solid), re-calculated TPS plan (dash-dot)
and in-house optimized IMPT plan (dashed) for the water equivalent head and neck case.
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